CareDx completes sale of Lab Products unit to Eurobio Scientific for $171.2 million cash

CareDx, Inc.

CareDx, Inc.

CDNA

0.00
  • CareDx completed the sale of its Lab Products business to Eurobio Scientific, closing on June 30, 2026.
  • Cash consideration totaled $171.2 million at closing, subject to customary post-closing adjustments.
  • The divested unit includes transplant-focused IVD PCR and NGS kit lines, including monitoring assays sold outside North America.
  • CareDx is refocusing on U.S. precision medicine testing services, patient support, digital solutions.
  • Additional financial impact details are expected with second-quarter 2026 results, including pro forma figures.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareDx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001217234-26-000038), on July 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.